CD44 and breast cancer: Third, HA ishighly biocompatible and can target CD44 overexpressed on breast cancer,including metastatic breast cancer cells.54−56 In our study,NP-ICG-HA exhibited no significant toxicity to cells, indicating itsgood translational potential.